- $940.24m
- $552.64m
- $455.00m
- 52
- 32
- 90
- 59
2019 December 31st | 2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Total Premiums Earned | |||||
Net Investment Income | |||||
Realized & Unrealized Gains / Losses | |||||
Total Revenue | 290 | 347 | 345 | 311 | 455 |
Losses, Benefits, and Adjustments | |||||
Amortization of Policy Acquisition Costs | |||||
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 550 | 632 | 847 | 574 | 556 |
Operating Profit | -260 | -285 | -501 | -263 | -101 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -282 | -363 | -521 | -298 | -147 |
Provision for Income Taxes | |||||
Net Income After Taxes | -282 | -363 | -521 | -298 | -147 |
Net Income Before Extraordinary Items | |||||
Net Income | -282 | -363 | -521 | -298 | -147 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -282 | -363 | -521 | -298 | -147 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -20.4 | -26 | -36.5 | -19.1 | -9.21 |
Dividends per Share |